It is reported that NAFLD patients had significantly lower levels of hepatic FXR expression, which suggests that FXR failure may be a contributing factor in the onset of NAFLD [19]. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.